Delivery Order SPE2DB22D3301-SPE2DB25FY5ML
- Not listed
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency (DLA) for the supply of Everolimus 5 mg tablets in quantities of 30, with a ceiling value of $5,193.76. The contract was awarded on August 5, 2025, with an ultimate completion date of August 6, 2025, and is structured as a firm fixed-price delivery order with no set-aside designation. Performance will take place at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Everolimus 5 mg tablets in a quantity of 30 units, valued at $5,193.76. This is a firm fixed price delivery order with no set-aside designation, representing a competitively awarded contract. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. The contract's ultimate completion...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Everolimus 5 mg tablets. The $1,720.92 contract has a completion date of February 12, 2024 and supports medical treatment programs and facilities within the Department of Defense. Amerisourcebergen Drug Corp holds an indefinite delivery contract with DLA valued at up to $999,999,999.00 through December 2025, which serves...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Everolimus 5 mg tablets (30-count packages) with a ceiling value of $44,765.09. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of August 13, 2025. The award is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- AmerisourceBergen Drug Corp was awarded a delivery order on July 14, 2025, by the Defense Logistics Agency's Medical Supply Chain for the supply of Everolimus 10 mg tablets (unit dose, 28-count packages) with a ceiling value of $1,358.26. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of July 15, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- AmerisourceBergen Drug Corp was awarded a delivery order on September 25, 2025, by the Defense Logistics Agency's Medical Supply Chain to supply Everolimus 0.5 mg tablets in a quantity of 60 units. This is a firm fixed price delivery order with a ceiling value of $4,497.40 and an ultimate completion date of September 26, 2025. The contract was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Everolimus 10 mg tablets in unit dose packaging (28 count). This is a firm fixed-price delivery order with a ceiling value of $1,358.26 and an ultimate completion date of September 25, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Everolimus 10 mg tablets (quantity: 30 count) under a firm fixed price contract valued at $18,147.63, with an ultimate completion date of September 19, 2025. This non-set-aside competitive award represents a single delivery order fulfilling federal pharmaceutical procurement needs for military and veteran healthcare systems. The vendor, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Everolimus 0.25 mg tablets (60-count unit) with a ceiling value of $10,068.17. This firm fixed-price delivery order, which is not set-aside and was competitively awarded, is scheduled for completion by August 28, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal...
- The Defense Logistics Agency awarded a $3,977.49 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Everolimus 0.75 mg, with a completion deadline of September 30, 2025. This non-set-aside contract was competitively awarded and performed at the contractor's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FY5MLDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,193.76 to AmerisourceBergen Drug Corp for the supply of Everolimus 5 mg tablets in quantities of 30 units. This non-set-aside, competitively awarded contract utilizes firm fixed-price pricing and is scheduled for completion by June 2, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that enables the company to supply pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has demonstrated significant capability in fulfilling federal medical procurement requirements through its extensive portfolio of contract awards with the DLA Medical Supply Chain. The company supplies a comprehensive range of pharmaceutical products including brand-name and generic medications, vaccines, and specialized medical commodities across multiple therapeutic domains to support military and veteran healthcare systems. As a critical vendor for federal medical procurement, AmerisourceBergen consistently secures competitively awarded contracts with delivery order structures and firm fixed pricing, positioning it as a key supplier for the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.2k | 5/30/25 |